Table 1.

Cohort characteristics for an analysis of time to initiation, resource utilization, and costs of care during the 6 months prior to treatment initiation for pediatric ART patients in Zambia.

	Patients with ≤2 clinic visits prior to ART initiation N = 511	Patients with >2 clinic visits prior to ART initiation N = 321	All patients N = 832
Age in years at presentation to care at study site, median [IQR]	4.1 [1.7–8.1]	3.6 [1.5–7.3]	3.9 [1.7–7.8]
Female, n (%)*	229 (53)	114 (47)	343 (51)
CD4 percentage at presentation to care at study site, median [IQR]**	13 [8–18]	14 [10–19]	13 [9–19]

ART: antiretroviral therapy; IQR: interquartile range.

*We only report gender information for the 679 patients for whom this information was available.

**CD4 percentage at presentation care at the study site was the earliest reported CD4 percentage within one month of presentation to care at the study site and prior to ART initiation. CD4 percentages were only available for 231 patients.